09:34 AM EDT, 04/22/2024 (MT Newswires) -- Bruker ( BRKR ) said Monday that it has signed an asset purchase agreement with NanoString Technologies, a provider of solutions for spatial transcriptomics and gene expression analysis, for approximately $392.6 million in cash and the assumption of certain liabilities.

Under the terms of the deal, Bruker ( BRKR ) said it will acquire substantially all of the assets and rights associated with NanoString's business, including the nCounter, GeoMx, CosMx and AtoMx product lines. These will become part of the Bruker Spatial Biology business, according to Bruker ( BRKR ).

Bruker ( BRKR ) said it expects to fund the acquisition with cash on hand and established debt instruments. The transaction, approved under a court-supervised Chapter 11 sale process, is expected to close in Q2 and is estimated to be dilutive to non-GAAP earnings by $0.15 to $0.20 for the rest of the year, the company added.